Evidence map›Paper›PMID 40341689›Full record

ReviewNPJ digital medicine2025

Patient agency and large language models in worldwide encoding of equity.

Antonis A Armoundas, Joseph Loscalzo

Abstract readReview
In one paragraph

Review in NPJ digital medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Review
  2. Large language models for tympanostomy patient education: readability and guideline adherence.European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery · 2026
    Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Review
  10. Review
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Antonis A ArmoundasCardiovascular Research Center, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA. armoundas.antonis@mgh.harvard.edu.
Joseph LoscalzoBroad Institute, Massachusetts Institute of Technology, Cambridge, MA, USA.

Funding

L-2-Hydroxyglutarate and Metabolic Remodeling in HypoxiaR01HL155107 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI Joseph Loscalzo · 2021 to 2026
$4.1M
Branched-chain Keto-acids and Aerobic Glycolysis in Vascular Smooth Muscle CellsR01HL166137 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI Joseph Loscalzo · 2023 to 2026
$2.8M
Prevention and Treatment of Ventricular TachyarrhythmiasR01HL135335 · NHLBI · MASSACHUSETTS GENERAL HOSPITAL · PI ARMOUNDAS, ANTONIS A · 2017 to 2020
$2.1M
Biomarker-guided optimization of transcutaneous vagal stimulation for atrial fibrillationR01HL161008 · NHLBI · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · PI Stavros Stavrakis · 2022 to 2026
$1.9M
A Medical-Grade Smart-Phone Based Monitoring System (Supplement)R21EB026164 · NIBIB · MASSACHUSETTS GENERAL HOSPITAL · PI ARMOUNDAS, ANTONIS A · 2018 to 2020
$668k
Utility of Vagal Stimulation to Prevent the Onset of Ventricular ArrhythmiasR21HL137870 · NHLBI · MASSACHUSETTS GENERAL HOSPITAL · PI ARMOUNDAS, ANTONIS A · 2017 to 2018
$468k
American Heart Association-American Stroke Association 957729NHLBI NIH HHS R01 HL135335NHLBI NIH HHS R01 HL155107NHLBI NIH HHS R01 HL161008NHLBI NIH HHS R01 HL166137NHLBI NIH HHS R21 HL137870NIBIB NIH HHS R21 EB026164
6 · The paper itself

Abstract

Large language models progressively result in improved ways of patient engagement and access to healthcare, reaching both an exciting and concerning time, as they no longer serve solely as a guide to clinicians, but, for the first time enable patients to make decisions that directly affect their health. We present the benefits and risks of this paradigm-shift in the practice of medicine, that offers the possibility of promoting health equity.

Identifiers

PMID40341689
PMCPMC12062359

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.